A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Clinical trial NCT07115043 · RECRUITING

Trial details

NCT number: NCT07115043
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Non-small Cell Lung Cancer Squamous Cell Carcinoma (Skin)Renal Cell Carcinoma Merkel Cell Carcinoma Triple Negative Breast Cancer Head and Neck Squamous Cell Carcinoma Gastric Cancer/Gastroesophageal Junction Cancer High Grade Serous Ovarian Carcinoma

Start date: 2025-07-29
Primary completion: 2029-10-02
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.